Bio-Rad Laboratories BIO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $532.2M+16.9% | $455.2M+21.4% | $374.9M+92.8% | $194.4M-71.0% | ||
| $157.6M-4.8% | $165.6M+5.7% | $156.7M+38.9% | $112.8M-15.7% | ||
| -$189.7M-18.4% | -$160.2M-893% | $20.2M+102% | -$1.21B-51.4% | ||
| $295.5M+45.1% | $203.6M-52.5% | $428.7M+98.7% | $215.7M— | ||
| $500K+25.0% | $400K-20.0% | $500K0.0% | $500K-83.4% | ||
| -$286.5M-30.9% | -$218.8M+48.6% | -$425.6M— | —— | ||
| $42.4M— | —— | -$30.1M— | —— | ||
| $374.6M+29.4% | $289.6M+32.7% | $218.2M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Rad Laboratories generate?
- Bio-Rad Laboratories (BIO) generated $510.4M in operating cash flow over the trailing twelve months.
- What is Bio-Rad Laboratories's free cash flow?
- After $153.2M of capital expenditures, Bio-Rad Laboratories's free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
- Where does Bio-Rad Laboratories's cash flow data come from?
- Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
